The Grünenthal Group
The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany.
We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients.
A research consortium under the direction of Grünenthal will receive a grant
The EU and the Federal State of North Rhein-Westphalia will provide €1.5 million
NeuRoWeg, a project with the University Hospitals of Cologne and Bonn, and a specialist scientific company, Life & Brain, will be supported with a grant of €1.5 million over the next three years.
The funding by the EU and the State of NRW will be used to support research into the molecular basis of neuropathic pain, and to develop novel test systems which will allow the efficacy of new analgesics for patients to be assessed more accurately and rapidly.